BIO vs CUBE · rev $2.58B vs P/E 25, rev $1.07B
BIO (BIO) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
BIO currently screens at market cap $0. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the BIO and CUBE stock pages for the full models.
Not investment advice.